RecruitingNCT02283112
Validation of Drug Assays in Various Biological Matrices
Sponsor
University of Liverpool
Enrollment
100 participants
Start Date
Oct 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- \> 18 years of age
Exclusion Criteria1
- Unable to give informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERantivirals, antimicrobials, oral contraceptive, erectile dysfunction agents
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02283112
Related Trials
Diagnosis and Management of Inflammatory and Infectious Diseases
NCT005577261 location
Home Hospital for Suddenly Ill Adults
NCT035242222 locations
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
NCT051899251 location
Copper Supplementation in Cirrhosis
NCT074715421 location
BLOOM: Pragmatic Feasibility Trial
NCT072873321 location